The first head-to-head randomised controlled trial to directly compare two different drug-coated balloons—the lower-dose density (2μg/mm2) Ranger and higher-dose density (3.5μg/mm2) IN.PACT—showed similar results with regard to effectiveness and safety through 12 months for femoropopliteal interventions, Dierk Scheinert (Leipzig, Germany) tells BLearning at LINC 2020.
Subscribe to receive BLearning videos here: www.blearning.net/registration
